#molecular diagnostics market
Text
Southeast Asia Molecular Diagnostics Market Outlook: Global Opportunity Analysis and Industry Forecast (2024-2031)
Meticulous Research®—a leading market research company, published a research report titled, ‘South East Asia Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology, Gene Testing), End User - Forecast to 2031’
Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=5775?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=25-04-2024
According to this latest publication from Meticulous Research®, the South East Asia molecular diagnostics market is projected to reach $891.87 million by 2031, at a CAGR of 7.8% from 2024 to 2031. The growth of the South East Asia molecular diagnostics market is driven by several factors, including the rising geriatric population, increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditure. Factors such as emerging medical tourism in South East Asian countries and increasing focus on companion diagnostics are a few opportunities that would help grow the market in the future. A shortage of skilled professionals could be considered a challenge for the South East Asia molecular diagnostics market. Moreover, the lack of harmonization of the medical device regulations across South East Asian countries and the high costs of molecular diagnostic tests restrain the growth of the market.
Key Players
The key players profiled in the South East Asia molecular diagnostics market report are Sansure Biotech, Inc. (China), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Illumina, Inc. (U.S.), Xiamen Zeesan Biotech Co., Ltd (China), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), Abbott Laboratories (U.S), Agilent Technologies, Inc. (U.S.).
Geographic Review
The South East Asia molecular diagnostics market is segmented by Offering (Kits & Reagents, Instruments, Software & Services), Test Type (Laboratory Tests and Point-of-Care (POC) Tests), Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarrays, Sequencing, Mass Spectrometry, and Other Technologies), Application (Infectious Diseases [Respiratory Diseases, Hepatitis, HIV, Chlamydia Trachomatis/Neisseria Gonorrhoeae, Human Papillomavirus (HPV), Healthcare-Associated Infections (HAIs), and Other Infectious Diseases], Oncology [Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Lymphoma, Leukemia, Cervical Cancer, and Other Cancer Types], Genetic Testing, Neurological Diseases, Cardiovascular Diseases, and Other Applications), End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Other End Users). The study also evaluates industry competitors and analyzes the regional and country-level markets.
Among offerings, in 2024, the kits and reagents segment is expected to account for the largest share of the market. The large share of the segment is attributed to the commercial availability of a diverse range of diagnostic reagents & consumables, the availability of diseases-specific test kits & assays, and the growing awareness regarding early disease diagnosis.
Request Sample@ https://www.meticulousresearch.com/request-sample-report/cp_id=5775?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=25-04-2024
Among test types, in 2024, the laboratory test segment is expected to account for the largest share of the market. The large share of the segment is attributed to the large number of laboratory tests available in hospitals and laboratories, and the high preference for laboratory tests owing to the accuracy of the test results supports the largest share of the market.
Among technologies, in 2024, the polymerase chain reaction (PCR) segment is expected to account for the largest share of the market. The large share of the segment is attributed to benefits, such as the ability to test multi-drug resistance, its use in several laboratories and clinical techniques, including DNA fingerprinting, detection of bacteria or viruses (particularly AIDS), and diagnosis of genetic disorders. Improved PCR testing capabilities in the laboratories during the COVID-19 pandemic to manage the growing burden also supported the segment’s largest share.
Among applications, in 2024, the infectious diseases segment is expected to account for the largest share of the market. The large share of the segment is attributed to the rising prevalence of infectious diseases, the increase in funding for the development of new infectious disease diagnostic tools, and the emergence of the COVID-19 pandemic. According to the World Health Organization (WHO), in 2022, the largest number of tuberculosis (TB) cases occurred in the South-East Asian region, with a prevalence of 46%. The increasing prevalence of such infections and diseases leads to the increased demand for rapid, easy-to-use, and affordable infectious disease testing tools, therefore driving the growth of the segment.
Among end users, the hospitals & clinics segment is expected to account for the largest share of the market in 2024. The large share of the segment is attributed to the increased number of hospitalizations due to various diseases requiring molecular diagnosis and the proliferation of hospitals and clinics in emerging countries, leading to the growth in the utilization of molecular diagnostic products. The emergence of new hospitals in South East Asian countries is leading to the growing demand for molecular diagnostic tests. For instance, in March 2023, Adventist Hospital was launched in Palangka Raya, Central Kalimantan, Indonesia, which is a 51-bed, state-of-the-art hospital that offers general medicine, surgery, obstetrics and gynecology, pediatrics, and critical care services to the inhabitants of Palangka Raya and nearby communities. This not only increases the demand for molecular tests but also provides these advanced technologies to people living in rural areas.
Among geographies, in 2024, Indonesia is expected to account for the largest share of the market. The large share of the segment is attributed to the increasing prevalence of communicable & non-communicable diseases, growing adoption of molecular diagnostics, increasing prevalence of cancer and musculoskeletal diseases, rising disposable income, improvements in the healthcare infrastructure, and the growing healthcare expenditure. The increasing prevalence of diseases is driving the need for better healthcare options among patients. In such cases, increasing healthcare expenditure can help increase people’s access to healthcare and improve the quality of care. For instance, the healthcare expenditure in Indonesia increased from USD 8.07 billion in 2019 to USD 17.62 billion in 2022.
Buy Now@ https://www.meticulousresearch.com/Checkout/49985136?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=25-04-2024
About Meticulous Research®:
Meticulous Research® is a leading global market research company that helps businesses make better decisions through insightful market intelligence and comprehensive industry analysis. With a repository of over [Number] reports spanning various industries, Meticulous Research® offers unparalleled expertise and actionable insights to empower organizations to navigate complex market challenges and achieve sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
0 notes
Text
Veterinary Molecular Diagnostics Market by Product (Kits & Reagents, System & Software), Technology (PCR, Microarray, DNA Seq), Animal Type (Companion, Livestock), Application (Infectious Disease, Genetics), End User (Hospital, Clinical Lab) - Forecast to 2029
#Veterinary Molecular Diagnostics Market#Veterinary Molecular Diagnostics#molecular diagnostics market#molecular diagnostics industry#veterinary#veterinary diagnostics#healthcare
0 notes
Text
The Molecular Diagnostics Market in 2023 is US$ 15.6 billion, and is expected to reach US$ 37.59 billion by 2031 at a CAGR of 11.62%.
#Molecular Diagnostics Market#Molecular Diagnostics Market Analysis#Molecular Diagnostics Market Overview
0 notes
Text
TEST BANK for Fundamentals of Molecular Virology 2nd Edition by Acheson
TEST BANK for Fundamentals of Molecular Virology 2nd Edition by Acheson USE PROMO CODE EXAM07https://limlibrary.creator-spring.com/listing/new-tb-fundamentals-of-m0lecul
0 notes
Text
#molecular diagnostics market report#molecular diagnostics industry report#molecular diagnostics market#molecular diagnostics market size#molecular diagnostics market share#molecular diagnostics market trends#molecular diagnostics market growth#molecular diagnostics market analysis#molecular diagnostics market forecast
0 notes
Text
Revolutionizing Disease Detection: The Promise of Advanced Molecular Diagnostics
Introduction:
In recent years, the field of molecular diagnostics has witnessed significant advancements, revolutionizing the way we diagnose and treat diseases. Traditional diagnostic methods have often been time-consuming and less accurate, but the advent of advanced molecular diagnostics has opened new possibilities for early detection, personalized treatment plans, and improved patient outcomes. This blog delves into the world of advanced molecular diagnostics, explores upcoming studies and research, and introduces the 5th Annual MarketsandMarkets Infectious Diseases and Molecular Diagnostics Conference, set to take place on 21st – 22nd March 2024 in London, UK.
Advanced Molecular Diagnostics:
Advanced molecular diagnostics encompass a range of techniques that analyze biomolecules at the genetic and molecular level, such as DNA, RNA, and proteins. These methods enable precise identification and characterization of pathogens, genetic mutations, and disease markers, thereby facilitating targeted therapies and individualized medicine. Some of the key technologies in this area include:
Next-Generation Sequencing (NGS): NGS has revolutionized genomics, allowing researchers to analyze DNA and RNA sequences on a massive scale. It has immense potential in detecting genetic variations, gene expression profiling, and understanding the molecular basis of diseases.
Polymerase Chain Reaction (PCR): PCR is a widely used technique for amplifying specific DNA segments, aiding in the detection of infections and genetic disorders with high sensitivity and specificity.
Mass Spectrometry: This technique is used to identify and quantify proteins and peptides, enabling rapid and accurate diagnosis of infectious diseases and certain cancers.
Microarrays: Microarray technology can simultaneously analyze thousands of genes or proteins, offering valuable insights into gene expression patterns and disease mechanisms.
CRISPR-based Diagnostics: The revolutionary CRISPR-Cas technology holds great potential in rapidly detecting infectious agents and genetic mutations, facilitating faster diagnosis and treatment decisions.
Upcoming Studies and Research:
The future of molecular diagnostics holds even more promise, with ongoing studies and research paving the way for groundbreaking innovations. Some of the upcoming areas of focus include:
Liquid Biopsies: Non-invasive liquid biopsies, which involve analysing circulating tumour DNA and other biomarkers in body fluids, could revolutionize cancer diagnosis and monitoring.
Single-Cell Analysis: Advancements in single-cell analysis will enable researchers to study individual cells' heterogeneity, leading to a deeper understanding of disease progression and treatment response.
Artificial Intelligence (AI) Integration: AI and machine learning algorithms will play an increasingly crucial role in interpreting complex molecular data, aiding in faster and more accurate diagnoses.
Point-of-Care Testing: Miniaturized, portable diagnostic devices will enhance accessibility to molecular testing, especially in resource-limited settings, allowing for timely disease management.
5th Annual MarketsandMarkets Infectious Diseases and Molecular Diagnostics Conference:
The 5th Annual MarketsandMarkets Infectious Diseases and Molecular Diagnostics Conference is a highly anticipated event that brings together experts, researchers, and industry professionals from around the world. What makes this annual conference unique is its comprehensive focus on the intersection of infectious diseases and molecular diagnostics, exploring the latest advancements and their impact on global healthcare.
Enquire Now
Benefits of Attending:
By attending this prestigious event, participants will:
Gain Insights: Learn from leading experts about the most recent advances in infectious disease diagnosis and molecular testing technologies.
Network: Connect with renowned researchers, industry leaders, and peers, fostering collaborations and opportunities for professional growth.
Stay Updated: Stay ahead of the curve by understanding upcoming research and trends in the field of molecular diagnostics.
Access Co-located Events: The conference will be co-located with the 8th Annual MarketsandMarkets Infection Control, Sterilization & Decontamination Conference, and the 3rd Annual MarketsandMarkets Minimally Invasive Surgery Conference, providing attendees with an even broader range of insights and networking opportunities.
Early Bird Discount:
Don't miss out on the early bird discount of 20%! Use the code IDMDL20 during registration to avail yourself of this special offer.
Conclusion:
As advanced molecular diagnostics continue to redefine healthcare, conferences like the 5th Annual MarketsandMarkets Infectious Diseases and Molecular Diagnostics Conference become crucial platforms for knowledge sharing and collaboration. Attendees will not only learn about cutting-edge research but also gain valuable insights into the future of precision medicine. Join us in London on 21st – 22nd March 2024 to be a part of this transformative event and leverage the early bird discount with the code IDMDL20.
0 notes
Text
#Molecular Diagnostics Market#Molecular Diagnostics#Molecular Diagnostics Market Size#Molecular Diagnostics Market Share#Molecular Diagnostics Market Growth#Molecular Diagnostics Market Trends#Molecular Diagnostics Market Overview#Molecular Diagnostics Market 2023#healthcare
1 note
·
View note
Text
Veterinary Molecular Diagnostics Market by Product (Kits & Reagents, System & Software), Technology (PCR, Microarray, DNA Seq), Animal Type (Companion, Livestock), Application (Infectious Disease, Genetics), End User (Hospital, Clinical Lab) - Forecast to 2029
#Veterinary Molecular Diagnostics Market#Veterinary Molecular Diagnostics#molecular diagnostics market#molecular diagnostics industry#veterinary diagnostics#animal health#healthcare
0 notes
Photo
Team "#Genes2Me" is thrilled to be a part of #ESHG_2023, Glasgow and excited to showcase the latest offerings in #Molecular_diagnostics, Cancer genetics and Precision Medicine. We are looking forward to meetings with distinguished customers, #distributors and other experts in the field. Don't Miss to Join us and Explore the latest developments! Meet us: ESHG (The European Society of Human Genetics), Glasgow, UK Date- Jun 10th to 12th Booth No. 718 Book your meeting Slot: https://www.genes2me.com/upcoming-events #eshg #cancer #genetics #exhibition #humangenetics #uk #madeinindia #manufacturer #meeting #diagnostics #kits #rtpcr #ivd
#genes2me#eshg#exhibition#molecular diagnostics market#molecular diagnostic#Diagnostic#made in idna#manufacturer
0 notes
Text
The Molecular Diagnostics Market in 2023 is US$ 15.6 billion, and is expected to reach US$ 37.59 billion by 2031 at a CAGR of 11.62%.
#Molecular Diagnostics Market#Molecular Diagnostics Market Analysis#Molecular Diagnostics Market Overview
0 notes
Text
#molecular diagnostics market#global molecular diagnostics market#molecular diagnostics market size#molecular diagnostics market share#molecular diagnostics market by product#molecular diagnostics market by application
1 note
·
View note
Text
Molecular Diagnostics Market Size to Grow with High CAGR during Forecast Period
Molecular Diagnostics Market Growth:
Washington, D.C., United States: Straits Research's latest report on, Molecular Diagnostics Market - Global Industry Overview and Forecast 2022-2030, highlights potential, risk factor analyses, and enhanced with strategic and tactical decision-making assistance. The growth and regulatory factors impacting information consumption, the availability of highly dependable items in the market, and the improvement in operating efficiency of Molecular Diagnostics industry players. According to the Straits Research, Molecular Diagnostics Market Size Anticipated to grow at a higher CAGR During the Forecast Period.Molecular Diagnostics Market Scope report covers market trends and development, drivers, capacities, technologies, and the changing dynamics of the Molecular Diagnostics Market.
Competitive Landscape
Some of the prominent players operating in the Molecular Diagnostics market are Abbott Laboratories, Agilent Technologies, Siemens AG, Biomérieux Sa, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation, Illumina, Roche Diagnostics, Hologic, and Qiagen
Get Free Request Sample Report @ https://straitsresearch.com/report/molecular-diagnostics-market/request-sample
Studies explore the effects of COVID-19 on the upstream, midstream, and downstream sectors of the industry. In addition, this analysis provides extensive market estimations by putting an emphasis on data covering numerous factors that encompass market dynamics such as market drivers, market barriers, market opportunities, market risks, and industry news and trends.
This research also provides a dashboard view of prominent Organization, highlighting their effective marketing tactics, market share and most recent advances in both historical and current settings.
Global Molecular Diagnostics Market: Segmentation
As a result of the Molecular Diagnostics market segmentation, the market is divided into sub-segments based on product type, application, as well as regional and country-level forecasts.
By Product & Service
Reagents & Kits
Instruments
Software & Services
By Technology
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing & Next-Generation Sequencing (NGS)
In Situ Hybridization
DNA Microarray
Other Technologies
By Application
Infectious Diseases
Hepatitis
HIV
CT/NG
HAIS
HPV
Tuberculosis
Influenza
Other Infectious Diseases
Oncology
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Other Cancers
Genetic Tests
Other Applications
By End-User
Hospital & Academic Laboratories
Reference Laboratories
Other End Users
Stay ahead of the competition with our in-depth analysis of the market trends!
Buy Now @ https://straitsresearch.com/buy-now/molecular-diagnostics-market
The following are the report's key features:
It gives useful information on the Global Molecular Diagnostics Market.
Information for the years 2022-2030 is provided.
Market-related important factors are highlighted.
The latest technological innovations, government restrictions, and developments are presented.
This paper investigates advertising and marketing techniques, market trends, and analysis.
Growth projections and analyses by forecast 2030.
The statistical analysis of the market's leading competitors is emphasised.
Molecular Diagnostics Market summary based on extensive study.
Other aspects of the report include:
Provides a complete review of important tactics in numerous firms, with an emphasis on corporate structure, R&D processes, localization strategies, manufacturing capabilities, sales, and performance.
Provides essential product portfolio information, including product planning, development, and positioning.
Analyzes the role of significant market participants, as well as their collaborations, mergers, and acquisitions.
Trending Report:
About Straits Research
Straits Research is dedicated to providing businesses with the highest quality market research services. With a team of experienced researchers and analysts, we strive to deliver insightful and actionable data that helps our clients make informed decisions about their industry and market. Our customized approach allows us to tailor our research to each client's specific needs and goals, ensuring that they receive the most relevant and valuable insights.
Contact Us
Email: [email protected]
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846
#Molecular Diagnostics Market#Molecular Diagnostics Market Share#Molecular Diagnostics Market Size#Molecular Diagnostics Market Research#Molecular Diagnostics Industry#What is Molecular Diagnostics?
0 notes
Last Seen Blogs
kiddokiddo1516
Kiddo Kiddo
interestinginformation-tk-blog
İnterestinginformation.tk
thinachanewberry-blog
Thinacha Amy Newberry
toknowonelifehasbreathedeasier
The sun will always rise.
vedasanas-blog
Untitled